ethambutol has been researched along with Bladder Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drechsler, A; Kirch, W | 1 |
| Takayasu, H; Waku, M | 1 |
2 other study(ies) available for ethambutol and Bladder Diseases
| Article | Year |
|---|---|
[Urinary bladder tuberculosis and Bacillus Calmette-Guérin instillation: reduced efficacy of bisoprolol in hypertension].
Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Antihypertensive Agents; Antitubercular Agents; BCG Vaccine; Bisoprolol; Blood Pressure; Carcinoma, Transitional Cell; Cardiac Complexes, Premature; Combined Modality Therapy; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Enzyme Induction; Ethambutol; Humans; Isoniazid; Male; Metabolic Clearance Rate; Neoplasm Recurrence, Local; Rifampin; Tuberculosis, Urogenital; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 2010 |
[Capreomycin therapy of vesicorenal tuberculosis].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antitubercular Agents; Cystoscopy; Ethambutol; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Nephrectomy; Radiography; Tuberculosis, Renal; Tuberculosis, Urogenital; Urinary Bladder Diseases; Urine | 1969 |